Insider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) CEO Sells 26,520 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY) CEO Jason Eric Evans sold 26,520 shares of the business’s stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.65, for a total value of $680,238.00. Following the sale, the chief executive officer now owns 560,698 shares of the company’s stock, valued at $14,381,903.70. The trade was a 4.52 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $25.58 on Tuesday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The stock has a market capitalization of $3.25 billion, a price-to-earnings ratio of -53.29, a PEG ratio of 17.77 and a beta of 2.60. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $35.29. The company’s 50-day simple moving average is $21.84 and its 200-day simple moving average is $26.93.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners’s revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.15 EPS. Equities analysts anticipate that Surgery Partners, Inc. will post 0.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on SGRY shares. JPMorgan Chase & Co. decreased their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Bank of America started coverage on shares of Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 target price on the stock. Macquarie reissued an “outperform” rating and issued a $34.00 price objective on shares of Surgery Partners in a research report on Tuesday, November 19th. Royal Bank of Canada reduced their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. Finally, UBS Group began coverage on Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 target price for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.56.

Hedge Funds Weigh In On Surgery Partners

Hedge funds have recently added to or reduced their stakes in the business. First Eagle Investment Management LLC raised its holdings in shares of Surgery Partners by 17.3% during the fourth quarter. First Eagle Investment Management LLC now owns 292,278 shares of the company’s stock worth $6,188,000 after purchasing an additional 43,100 shares during the period. Raymond James Financial Inc. acquired a new stake in Surgery Partners during the fourth quarter worth about $10,130,000. Charles Schwab Investment Management Inc. raised its stake in Surgery Partners by 8.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 834,417 shares of the company’s stock worth $17,665,000 after acquiring an additional 61,671 shares during the period. NINE MASTS CAPITAL Ltd bought a new position in Surgery Partners in the fourth quarter worth about $606,000. Finally, Versor Investments LP boosted its stake in Surgery Partners by 450.0% in the fourth quarter. Versor Investments LP now owns 46,200 shares of the company’s stock valued at $978,000 after acquiring an additional 37,800 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.